Pathware

Pathware

Private
Golden, ColoradoHealthcare & Life Scienceshttps://www.pathware.com/

Last Round

Series A

Apr 19, 2022

Total Funding Raised

$8.46M

Momentum Score

25 /100

Company Overview

Pathware is a medical technology company that has developed a digital pathology platform intended for point-of-care diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Medical Devices, Telemedicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Usage-Based SaaS, Revenue Share

AI Layer

Application

Keywords

digital pathologypoint of care diagnosticsbiopsy quality assessmentwhole-slide imagingWSIdiagnostic AIcomputational pathologytelepathologysample adequacymedical imaging AIclinical decision supportpathology workflowremote pathologymedical devicefine-needle aspiration

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pathware Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Pathware Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AApr 19, 2022
SeedSep 9, 2019

Key People

Founding team and executive leadership

TJ Meyer

Chief Executive Officer

Executive Team

Troy Holsing

Chief Technology Officer

Executive Team

Pathware Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 23, 2026

    Grew 25% QoQ, from 12 to 15 employees.

  • Apr 19, 2022

    $7M round led by UnityPoint Health Ventures and Level Eight Ventures.

Pathware Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pathware Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pathware's valuation, stock price, and market status.

Firmographic Details

HeadquartersGolden, Colorado
Employee Range15
Year Founded2017
Last FundingApr 19, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.